Scientists at Argentine biotech firm Kheiron have produced the world's first genetically edited horses using a technique called CRISPR-Cas9. The horses were born last October and November.

It's crunch time for biotech projects started on a bet that the industry would shake off its multiyear malaise.

Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

The increasing prevalence of chronic diseases, advances in biotechnology, and increasing research and development investments propel the microplate reader adoption in laboratories. Hence ...

This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS application, while offering — out of the box — the functionality and workflows needed by biotech and ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Immunovant, Inc. (NASDAQ:IMVT) stands against other ...

Merck's (NYSE:MRK) recent acquisition of rights to Chinese biotech LaNova Medicines' cancer candidate LM-299 in a deal worth up to $3.3B underscores Big Pharma's appetite for best-in-class assets ...